Lan Cui

ORCID: 0000-0001-5530-4528
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nanoparticle-Based Drug Delivery
  • Nanoplatforms for cancer theranostics
  • Advanced battery technologies research
  • Electrocatalysts for Energy Conversion
  • Dendrimers and Hyperbranched Polymers
  • Advancements in Battery Materials
  • Mesoporous Materials and Catalysis
  • Nanomaterials for catalytic reactions
  • Carbon Nanotubes in Composites
  • Advanced Nanomaterials in Catalysis
  • Chalcogenide Semiconductor Thin Films
  • Copper-based nanomaterials and applications
  • Chromium effects and bioremediation
  • Quantum Dots Synthesis And Properties
  • RNA Interference and Gene Delivery
  • Erythrocyte Function and Pathophysiology
  • Adsorption and biosorption for pollutant removal
  • Catalytic Processes in Materials Science
  • Covalent Organic Framework Applications
  • Gold and Silver Nanoparticles Synthesis and Applications
  • Advanced Battery Materials and Technologies
  • Graphene research and applications
  • Extracellular vesicles in disease
  • Innovative Microfluidic and Catalytic Techniques Innovation
  • Supercapacitor Materials and Fabrication

Henan University of Technology
2022-2024

Zhengzhou University
2015-2024

Zhengzhou University of Science and Technology
2019

Tianjin University
2006-2018

Zinc-air batteries offer a possible solution for large-scale energy storage due to their superhigh theoretical density, reliable safety, low cost, and long durability. However, widespread application is hindered by power density. Herein, multiscale structural engineering of Ni-doped CoO nanosheets (NSs) zinc-air with superior high density/energy density durability reported the first time. In micro- nanoscale, robust 2D architecture together numerous nanopores inside provides an advantageous...

10.1002/adma.201804653 article EN publisher-specific-oa Advanced Materials 2018-10-04

Manganese-based oxides have exhibited high promise as noncoinage alternatives to Pt/C for catalyzing oxygen reduction reaction (ORR) in basic solution and a mix of Mn3+/4+ valence is believed be vital achieving optimum ORR performance. Here, it proposed that, distinct from the most studied perovskites spinels, Mn-based mullites with equivalent molar ratio Mn3+ Mn4+ provide unique platform maximize role Mn facile kinetics by introducing modest content deficiency, which also beneficial...

10.1002/smll.201603903 article EN Small 2017-02-13

Surface modification of mesoporous silica nanoparticles (MSNs) is a promising way to enhance therapeutic efficacy and minimize side effects anticancer drugs. In this work, MSNs with reduced particle size optimum pore diameter were obtained catalyzed by ammonia/triethanolamine. view the negatively charged carboxymethyl chitosan (CMC) positively oligosaccharide (CS), pH-triggered charge-reversal CS/CMC bilayer was designed as stimuli-responsive switch for via protonation deprotonation effect....

10.1021/acsabm.8b00830 article EN ACS Applied Bio Materials 2019-04-04

Multidrug resistance (MDR) is frequently induced after long-term exposure to reduce the therapeutic effect of chemotherapeutic drugs, which always associated with overexpression efflux proteins, such as P-glycoprotein (P-gp). Nano-delivery technology can be used an efficient strategy overcome tumor MDR. In this study, mesoporous silica nanoparticles (MSNs) were synthesized and linked a disulfide bond then coated lipid bilayers. The functionalized shell/core delivery systems (HT-LMSNs-SS@DOX)...

10.3390/ijms25105553 article EN International Journal of Molecular Sciences 2024-05-20

The surface charge of nanocarriers inevitably affects drug delivery efficiency; however, the cancer cell specificity, anti-inflammatory effects, and charge-reversal points remain to be further addressed in biomedical applications. aim this study was comprehensively assess specificity DOX-loaded mesoporous silica-chitosan oligosaccharide-carboxymethyl chitosan nanoparticles (DOX@MSNs-COS-CMC) MCF-7 HeLa cells, inhibit production inflammatory cytokines, improve accumulation tumor site....

10.1021/acs.molpharmaceut.0c00004 article EN Molecular Pharmaceutics 2020-03-30
Coming Soon ...